![Josh Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josh Cohen
Fondateur chez
AMYLYX PHARMACEUTICALS, INC.
Fortune : 64 M $ au 30/06/2026
Profil
Joshua B. Cohen is the founder of Amylyx Pharmaceuticals, Inc., founded in 2013, holding the title of Co-Chief Executive Officer & Director since 2014.
Mr. Cohen is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen currently holds the position of Director at Practice XYZ LLC.
Mr. Cohen completed undergraduate education at Brown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 3 583 548 ( 3,24% ) | 64 M $ | 30/06/2026 |
Postes actifs de Josh Cohen
| Sociétés | Poste | Début |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Fondateur | 01/01/2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Directeur/Membre du Conseil | - |
Anciens postes connus de Josh Cohen
| Sociétés | Poste | Fin |
|---|---|---|
Brown Biotechnology Investment Group | Fondateur | - |
Formation de Josh Cohen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Offers online platform which supports to share best practice videos | Technology Services |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Brown Biotechnology Investment Group |
